MedCognetics leverages advanced artificial intelligence (AI) technologies to enhance the efficiency and accuracy of breast cancer detection. Their AI system is designed to assist radiologists by prioritizing mammograms that are flagged as suspicious, thereby addressing the challenges posed by radiologist shortages and heavy workloads. This technology enables radiologists to manage their workflow more effectively, allowing them to triage cases based on the level of suspicion, which is crucial in improving patient outcomes.

The company emphasizes the importance of unbiased AI, achieved through the integration of diverse patient data sourced globally. This approach aims to enhance the accuracy of breast cancer detection across different populations, ultimately striving to reduce mortality rates by facilitating early diagnosis. MedCognetics' commitment to improving healthcare outcomes is evident in their focus on empowering radiologists and addressing the pressing issue of burnout in the field.

United States

MedCognetics provides an advanced AI software platform which integrates into the radiology workflow. The AI platform is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating more predictable medical outcomes and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com.

MedCognetics

Company Details